Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.32

Margin Of Safety %

28

Put/Call OI Ratio

0.72

EPS Next Q Diff

-0.38

EPS Last/This Y

7.43

EPS This/Next Y

1.31

Price

278.04

Target Price

296.12

Analyst Recom

1.59

Performance Q

6.23

Relative Volume

0.53

Beta

0.89

Ticker: LH




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15LH270.370.704.896799
2025-08-18LH270.520.630.623181
2025-08-19LH275.930.630.243252
2025-08-20LH278.110.620.013302
2025-08-21LH276.60.370.944673
2025-08-22LH278.180.380.014710
2025-08-25LH276.150.450.354160
2025-08-26LH278.440.450.214180
2025-08-27LH279.330.462.444179
2025-08-28LH275.270.670.225009
2025-08-29LH278.110.660.415040
2025-09-02LH273.720.661.005081
2025-09-03LH273.830.660.175084
2025-09-04LH275.060.660.785090
2025-09-05LH278.620.650.905093
2025-09-08LH277.270.650.015099
2025-09-09LH278.080.730.084791
2025-09-10LH272.940.720.294816
2025-09-11LH279.830.720.154822
2025-09-12LH277.990.720.754858
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15LH270.4317.9476.216.32
2025-08-18LH270.4917.9480.816.32
2025-08-19LH275.7717.9506.216.32
2025-08-20LH278.0817.9491.516.32
2025-08-21LH276.6817.9473.416.32
2025-08-22LH278.1517.9488.016.32
2025-08-25LH276.1717.9470.616.32
2025-08-26LH278.4517.9491.616.32
2025-08-27LH279.3217.9484.416.32
2025-08-28LH275.2417.9460.816.32
2025-08-29LH278.1217.9494.016.32
2025-09-02LH273.6117.9459.116.32
2025-09-03LH273.7617.9650.816.32
2025-09-04LH275.2517.9657.716.32
2025-09-05LH278.6717.9672.316.32
2025-09-08LH277.2117.9646.216.32
2025-09-09LH278.3917.9660.216.32
2025-09-10LH273.0317.9626.916.32
2025-09-11LH279.7217.9690.516.32
2025-09-12LH278.0417.9645.016.32
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15LH-13.490.463.32
2025-08-18LH-13.490.553.32
2025-08-19LH-13.850.553.32
2025-08-20LH-13.850.553.32
2025-08-21LH-13.460.553.32
2025-08-22LH-13.100.553.32
2025-08-25LH-13.103.533.32
2025-08-26LH-13.103.533.32
2025-08-27LH-13.043.533.23
2025-08-28LH-12.683.533.23
2025-08-29LH-12.683.533.23
2025-09-02LH-12.683.883.23
2025-09-03LH-12.683.883.23
2025-09-04LH-12.683.883.23
2025-09-05LH-11.173.883.23
2025-09-08LH-11.023.843.23
2025-09-09LH-11.023.843.23
2025-09-10LH-11.023.843.23
2025-09-11LH-11.023.843.32
2025-09-12LH-11.023.843.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

4.35

Avg. EPS Est. Current Quarter

4.13

Avg. EPS Est. Next Quarter

3.97

Insider Transactions

-11.02

Institutional Transactions

3.84

Beta

0.89

Average Sales Estimate Current Quarter

3557

Average Sales Estimate Next Quarter

3576

Fair Value

354.6

Quality Score

66

Growth Score

79

Sentiment Score

71

Actual DrawDown %

1.9

Max Drawdown 5-Year %

-34.5

Target Price

296.12

P/E

30.65

Forward P/E

15.8

PEG

3.17

P/S

1.71

P/B

2.72

P/Free Cash Flow

18.31

EPS

9.07

Average EPS Est. Cur. Y​

16.32

EPS Next Y. (Est.)

17.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.66

Relative Volume

0.53

Return on Equity vs Sector %

-15.9

Return on Equity vs Industry %

-1.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

645
Labcorp Holdings Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 70000
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading